In H460 lung cancer cells, gigantol was shown to destabilize tumor integrity via suppression of the PI3K/Akt/mTOR and JAK/STAT pathways at concentrations of 20–200 μM [226]. The gene discussed is AKT1; the disease is lung carcinoma.